Home › MOTORIKA MEDICAL (ISRAEL) LTD › REOGO

REOGO

MOTORIKA MEDICAL (ISRAEL) LTD · Model 09 · UDI-DI 07290017844114

IKK Prescription

510(k) clearances

Adverse events

Recalls

Facilities

Description

The ReoGoTM therapy platform is a computerized robotics-based system for retraining patients with motor limitations, recovering from CVA or other neuromuscular conditions. The Motorika ReoGo™ System is rehabilitative exercise device intended for medical purposes, such as to measure, evaluate, and increase the strength of muscles and the range of motion of joints specifically designed to prevent the adhesion and contracture of joints, to improve the patients’ range of motion and functional capabilities of the upper extremity.

Recalls

Date	Firm	Reason
2023-05-31	Trexo Robotics Holdings Inc.	Electrical issues that could potentially render the device non-functional, give off electromagnetic influence to surrounding equipment, and risk of burns when in use.
2020-06-08	Hocoma AG	The motor controller may fail, which can potentially lead to an error in functionality of the Body Weights Support Rope, which means that the rope can go up or down in an uncontrol
2013-12-03	MedX Holdings, Inc.	Review of DHRs revealed that HiPot, Continuity, load and friction re-testing was not completed on these devices during manufacturing.
2012-05-05	Interactive Motion Technologies, Inc.	Unsupervised patient could potentially mis-use the device and remove or rotate a protective cover and expose a potential pinch hazard.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.